Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve

  1. Yaeram Jeong
  2. Chung-ha O Davis
  3. Aaron Muscarella
  4. Hector H Navarro
  5. Viraj Deshpande
  6. Lucy G Moore
  7. Keun-Young Kim
  8. Mark H Ellisman
  9. Nicholas Marsh-Armstrong  Is a corresponding author
  1. University of California, Davis, United States
  2. Stanford University, United States
  3. University of California, San Diego, United States

Abstract

We previously described a process whereby mitochondria shed by retinal ganglion cell (RGC) axons are transferred to and degraded by surrounding astrocytes in the optic nerve head of mice. Since the mitophagy receptor Optineurin (OPTN) is one of few large-effect glaucoma genes and axonal damage occurs at the optic nerve head in glaucoma, here we explored whether OPTN mutations perturb the transcellular degradation of mitochondria. Live-imaging of Xenopus laevis optic nerves revealed that diverse human mutant but not wildtype OPTN increase stationary mitochondria and mitophagy machinery and their colocalization within, and in the case of the glaucoma-associated OPTN mutations also outside of, RGC axons. These extra-axonal mitochondria are degraded by astrocytes. Our studies demonstrate that expression of OPTN carrying a glaucoma-associated mutation results in increased transcellular degradation of axonal mitochondria.

Data availability

Data has been uploaded to Dryad

Article and author information

Author details

  1. Yaeram Jeong

    Department of Ophthalmology and Vision Science, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Chung-ha O Davis

    Neurosciences Program, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Aaron Muscarella

    Department of Neurosciences, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Hector H Navarro

    Department of Ophthalmology and Vision Science, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Viraj Deshpande

    Department of Ophthalmology and Vision Science, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Lucy G Moore

    Department of Ophthalmology and Vision Science, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Keun-Young Kim

    Department of Neurosciences, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Mark H Ellisman

    Department of Neurosciences, University of California, San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Nicholas Marsh-Armstrong

    Department of Ophthalmology and Vision Science, University of California, Davis, Davis, United States
    For correspondence
    nmarsharmstrong@ucdavis.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7843-6651

Funding

National Eye Institute (EY026471)

  • Nicholas Marsh-Armstrong

National Eye Institute (EY029087)

  • Nicholas Marsh-Armstrong

National Eye Institute (P30-EY012576)

  • Nicholas Marsh-Armstrong

National Institutes of Health (U24 NS120055)

  • Nicholas Marsh-Armstrong

National Institutes of Health (ISI0OD021784)

  • Nicholas Marsh-Armstrong

National Institutes of Health (GM82949)

  • Nicholas Marsh-Armstrong

National Science Foundation (2014862-UTA20-000)

  • Nicholas Marsh-Armstrong

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The study was carried out in accordance with recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal work was carried out according to approved institutional care and use committee protocols (#22908) of the University of California Davis. Surgeries and imaging were carried out under MS-222 anesthesia and all efforts were made to minimize pain or distress to the animals.

Copyright

© 2025, Jeong et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yaeram Jeong
  2. Chung-ha O Davis
  3. Aaron Muscarella
  4. Hector H Navarro
  5. Viraj Deshpande
  6. Lucy G Moore
  7. Keun-Young Kim
  8. Mark H Ellisman
  9. Nicholas Marsh-Armstrong
(2025)
Glaucoma-associated Optineurin mutations increase transcellular degradation of mitochondria in a vertebrate optic nerve
eLife 14:e103844.
https://doi.org/10.7554/eLife.103844

Share this article

https://doi.org/10.7554/eLife.103844